Antimicrobial resistance (AMR) is one of the biggest threats facing the world but arguably not enough is being done by both pharma companies and governments around the world.
Pascale Farjas, global category manager for drug delivery company Nemera examines the design features that help improve adherence for patients using nasal spray devices.
Stanley Chia, senior vice president at e-invoicing supplier, Tungsten Network, details the importance of secure supply chains in the age of the counterfeit drug.
Charlie Johnson, CEO of biotechnology company ADC Bio, explains how substantial cost savings and faster time to market is achievable through the novel concept of combining the bioconjugation and purification steps.
Dr David Lewis, director of aerosol research at pharmaceutical company Chiesi, discusses how the company is focusing on new technologies to advance drug discvoery and future-proof innovation.
In the latest Meet the maker, EPM speaks to Ben Wylie, senior product manager at ChargePoint Technology who talks about the challenges of the industry and what it needs to remain innovative.
Jennifer Lopez, director, solutions delivery at Maetrics discusses why heightened due diligence is needed for pharmaceutical manufacturers during mergers and acquisitions.
